• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用黑色素转铁蛋白抗体和他莫昔芬偶联的固体脂质纳米粒增强依托泊苷穿过血脑屏障的能力以抑制脑肿瘤生长

Enhanced delivery of etoposide across the blood-brain barrier to restrain brain tumor growth using melanotransferrin antibody- and tamoxifen-conjugated solid lipid nanoparticles.

作者信息

Kuo Yung-Chih, Wang I-Hsin

机构信息

a Department of Chemical Engineering , National Chung Cheng University , Chia-Yi , Taiwan , Republic of China.

出版信息

J Drug Target. 2016 Aug;24(7):645-54. doi: 10.3109/1061186X.2015.1132223. Epub 2016 Jan 15.

DOI:10.3109/1061186X.2015.1132223
PMID:26768307
Abstract

Melanotransferrin antibody (MA) and tamoxifen (TX) were conjugated on etoposide (ETP)-entrapped solid lipid nanoparticles (ETP-SLNs) to target the blood-brain barrier (BBB) and glioblastom multiforme (GBM). MA- and TX-conjugated ETP-SLNs (MA-TX-ETP-SLNs) were used to infiltrate the BBB comprising a monolayer of human astrocyte-regulated human brain-microvascular endothelial cells (HBMECs) and to restrain the proliferation of malignant U87MG cells. TX-grafted ETP-SLNs (TX-ETP-SLNs) significantly enhanced the BBB permeability coefficient for ETP and raised the fluorescent intensity of calcein-AM when compared with ETP-SLNs. In addition, surface MA could increase the BBB permeability coefficient for ETP about twofold. The viability of HBMECs was higher than 86%, suggesting a high biocompatibility of MA-TX-ETP-SLNs. Moreover, the efficiency in antiproliferation against U87MG cells was in the order of MA-TX-ETP-SLNs  >  TX-ETP-SLNs  >  ETP-SLNs  >  SLNs. The capability of MA-TX-ETP-SLNs to target HBMECs and U87MG cells during internalization was verified by immunochemical staining of expressed melanotransferrin. MA-TX-ETP-SLNs can be a potent pharmacotherapy to deliver ETP across the BBB to GBM.

摘要

将黑素转铁蛋白抗体(MA)和他莫昔芬(TX)偶联到包载依托泊苷(ETP)的固体脂质纳米粒(ETP-SLNs)上,以靶向血脑屏障(BBB)和多形性胶质母细胞瘤(GBM)。MA和TX偶联的ETP-SLNs(MA-TX-ETP-SLNs)用于穿透由人星形胶质细胞调节的人脑微血管内皮细胞(HBMECs)单层组成的血脑屏障,并抑制恶性U87MG细胞的增殖。与ETP-SLNs相比,TX接枝的ETP-SLNs(TX-ETP-SLNs)显著提高了ETP的血脑屏障渗透系数,并提高了钙黄绿素-AM的荧光强度。此外,表面MA可使ETP的血脑屏障渗透系数增加约两倍。HBMECs的活力高于86%,表明MA-TX-ETP-SLNs具有高生物相容性。此外,对U87MG细胞的抗增殖效率顺序为MA-TX-ETP-SLNs>TX-ETP-SLNs>ETP-SLNs>SLNs。通过对表达的黑素转铁蛋白进行免疫化学染色,验证了MA-TX-ETP-SLNs在内化过程中靶向HBMECs和U87MG细胞的能力。MA-TX-ETP-SLNs可以作为一种有效的药物疗法,将ETP通过血脑屏障递送至GBM。

相似文献

1
Enhanced delivery of etoposide across the blood-brain barrier to restrain brain tumor growth using melanotransferrin antibody- and tamoxifen-conjugated solid lipid nanoparticles.使用黑色素转铁蛋白抗体和他莫昔芬偶联的固体脂质纳米粒增强依托泊苷穿过血脑屏障的能力以抑制脑肿瘤生长
J Drug Target. 2016 Aug;24(7):645-54. doi: 10.3109/1061186X.2015.1132223. Epub 2016 Jan 15.
2
Conjugation of melanotransferrin antibody on solid lipid nanoparticles for mediating brain cancer malignancy.黑色素转铁蛋白抗体在固体脂质纳米粒上的偶联用于介导脑癌恶性肿瘤。
Biotechnol Prog. 2016 Mar;32(2):480-90. doi: 10.1002/btpr.2214. Epub 2015 Dec 31.
3
Brain targeted delivery of carmustine using solid lipid nanoparticles modified with tamoxifen and lactoferrin for antitumor proliferation.使用经他莫昔芬和乳铁蛋白修饰的固体脂质纳米粒实现卡莫司汀的脑靶向递送以抑制肿瘤增殖。
Int J Pharm. 2016 Feb 29;499(1-2):10-19. doi: 10.1016/j.ijpharm.2015.12.054. Epub 2015 Dec 22.
4
Dual targeting of solid lipid nanoparticles grafted with 83-14 MAb and anti-EGF receptor for malignant brain tumor therapy.接枝83-14单克隆抗体和抗表皮生长因子受体的固体脂质纳米粒对恶性脑肿瘤治疗的双重靶向作用
Life Sci. 2016 Feb 1;146:222-31. doi: 10.1016/j.lfs.2016.01.025. Epub 2016 Jan 16.
5
Inhibition against growth of glioblastoma multiforme in vitro using etoposide-loaded solid lipid nanoparticles with p-aminophenyl-α-D-manno-pyranoside and folic acid.使用负载依托泊苷的固体脂质纳米粒与对氨基苯基-α-D-甘露吡喃糖苷和叶酸在体外抑制多形性胶质母细胞瘤的生长
J Pharm Sci. 2015 May;104(5):1804-14. doi: 10.1002/jps.24388. Epub 2015 Feb 18.
6
Delivering etoposide to the brain using catanionic solid lipid nanoparticles with surface 5-HT-moduline.用表面具有 5-HT-修饰素的 catanionic 固体脂质纳米粒向脑部递送依托泊苷。
Int J Pharm. 2014 Apr 25;465(1-2):132-42. doi: 10.1016/j.ijpharm.2014.02.008. Epub 2014 Feb 10.
7
Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles.利用乳铁蛋白和叶酸修饰的聚乳酸-共-羟基乙酸纳米粒靶向递送依托泊苷抑制人多形性胶质母细胞瘤的生长。
Int J Pharm. 2015 Feb 1;479(1):138-49. doi: 10.1016/j.ijpharm.2014.12.070. Epub 2015 Jan 2.
8
Solid lipid nanoparticles carrying chemotherapeutic drug across the blood-brain barrier through insulin receptor-mediated pathway.载化疗药物的固体脂质纳米粒通过胰岛素受体介导途径穿越血脑屏障。
J Drug Target. 2013 Sep;21(8):730-8. doi: 10.3109/1061186X.2013.812094. Epub 2013 Jul 1.
9
Targeting delivery of saquinavir to the brain using 83-14 monoclonal antibody-grafted solid lipid nanoparticles.利用 83-14 单克隆抗体接枝固体脂质纳米粒靶向递送至脑部的沙奎那韦。
Biomaterials. 2013 Jul;34(20):4818-30. doi: 10.1016/j.biomaterials.2013.03.013. Epub 2013 Mar 29.
10
Paclitaxel and naringenin-loaded solid lipid nanoparticles surface modified with cyclic peptides with improved tumor targeting ability in glioblastoma multiforme.载紫杉醇和柚皮素的固体脂质纳米粒经环肽表面修饰后,提高了在多形性胶质母细胞瘤中的肿瘤靶向能力。
Biomed Pharmacother. 2021 Jun;138:111461. doi: 10.1016/j.biopha.2021.111461. Epub 2021 Mar 9.

引用本文的文献

1
Advances in brain-targeted delivery strategies and natural product-mediated enhancement of blood-brain barrier permeability.脑靶向递送策略及天然产物介导增强血脑屏障通透性的研究进展。
J Nanobiotechnology. 2025 May 26;23(1):382. doi: 10.1186/s12951-025-03415-w.
2
Nanotherapy of Glioblastoma-Where Hope Grows.胶质母细胞瘤的纳米疗法——希望之所系
Int J Mol Sci. 2025 Feb 20;26(5):1814. doi: 10.3390/ijms26051814.
3
Drug Delivery Across the Blood-Brain Barrier: A New Strategy for the Treatment of Neurological Diseases.药物透过血脑屏障的递送:治疗神经疾病的新策略。
Pharmaceutics. 2024 Dec 19;16(12):1611. doi: 10.3390/pharmaceutics16121611.
4
Solid Lipid Nanoparticles: Multitasking Nano-Carriers for Cancer Treatment.固体脂质纳米粒:用于癌症治疗的多功能纳米载体。
Pharmaceutics. 2023 Mar 3;15(3):831. doi: 10.3390/pharmaceutics15030831.
5
DNA Repair and Therapeutic Strategies in Cancer Stem Cells.癌症干细胞中的DNA修复与治疗策略
Cancers (Basel). 2023 Mar 22;15(6):1897. doi: 10.3390/cancers15061897.
6
Lipid Nanoparticles Functionalized with Antibodies for Anticancer Drug Therapy.用抗体功能化的脂质纳米颗粒用于抗癌药物治疗。
Pharmaceutics. 2023 Jan 8;15(1):216. doi: 10.3390/pharmaceutics15010216.
7
Lipid nanostructures for targeting brain cancer.用于靶向脑癌的脂质纳米结构
Heliyon. 2021 Sep 16;7(9):e07994. doi: 10.1016/j.heliyon.2021.e07994. eCollection 2021 Sep.
8
Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain through BBB.固体脂质纳米粒(SLNs):一种通过血脑屏障靶向脑部的先进药物递送系统。
Pharmaceutics. 2021 Jul 31;13(8):1183. doi: 10.3390/pharmaceutics13081183.
9
Inhibition of DNA-PK potentiates the synergistic effect of NK314 and etoposide combination on human glioblastoma cells.抑制 DNA-PK 可增强 NK314 和依托泊苷联合对人胶质母细胞瘤细胞的协同作用。
Mol Biol Rep. 2020 Jan;47(1):67-76. doi: 10.1007/s11033-019-05105-x. Epub 2019 Oct 3.
10
Macromolecular Drug Carriers for Targeted Glioblastoma Therapy: Preclinical Studies, Challenges, and Future Perspectives.用于靶向胶质母细胞瘤治疗的大分子药物载体:临床前研究、挑战与未来展望
Front Oncol. 2018 Dec 17;8:624. doi: 10.3389/fonc.2018.00624. eCollection 2018.